Sida planicaulis is a weed thought to have originated in Brazil, the place it’s current in considerable portions, but in addition this plant can also be present in south-central Florida, Indian Ocean Islands, and the Pacific Islands. Sida planicaulis produces neurotoxicity that adversely impacts livestock breeding with heavy animal losses and consequent destructive affect on Brazil’s economic system.
The intention of this research was to find out the chemical profile, cytotoxic and genotoxic results of ethanolic extracts of S. planicaulis collected in winter (leaf extract) and summer season (leaf extract and leaf + flower extract) utilizing an in vitro mannequin of human neuroblastoma cell line SH-SY5Y. Phytochemical screening demonstrated the presence of alkaloids, flavonoids, and apolar compounds.
Rutin, quercetin, and swainsonine had been detected by HPLC and GC/MS, respectively. Phosphorus, potassium, iron, and zinc had been the inorganic parts discovered. Extracts produced cytotoxicity in any respect concentrations examined (7-4,000 μg/ml) as evidenced by the colorimetric assay [3-(4,5-dimethyl-thiazol-2-yl) -2,5-diphenyl-tetrazolium bromide (MTT)]. Based mostly upon the alkaline comet assay extracts had been discovered to induce genotoxicity at concentrations starting from 0.437 to 7 μg/ml.
DNA harm produced by extracts was affirmed utilizing a modified comet assay with the enzymes Endo III and FPG in a focus dependent method. Additional, enzyme-modified comet assay confirmed each oxidized purines and pyrimidines, and consequently oxidative stress was associated to genomic instability and cell demise. Information counsel that low concentrations of ethanolic extracts of S. planicaulis (completely different seasons) induced elevated DNA harm associated to oxidative stress and chemical composition.
CELL CYCLE STRESS IN NORMAL HUMAN CELLS: A ROUTE TO “FIRST CELLS” (WITH/WITHOUT FITNESS GAIN) AND CANCER-LIKE CELL-SHAPE CHANGES
We’ve introduced an in vitro trackable mannequin system, atavistic induced from conservation in our genome, which strongly is relevant to tumorigenesis begin and evolution. The inducing issue was demise alerts to proliferating regular human cells (major cell strains), which respon-ded by a particular kind of tetraploidization, chromosomes with 4-chromatids (diplochromosomes, earlier described in most cancers cells).
The response included cell cycle stress, which extended S-period with results of mitotic slippage course of, forming the particular 4n cells by re-replication of diploid cells, which confirmed cell division functionality to sudden, genome diminished diploid cells which remarkably, confirmed health acquire. This distinctive response by means of cell cycle stress and mitotic slippage course of was additional found to be linked to a somewhat particular attribute of the, 4n nucleus.
The nucleus turned, self-inflicted, 90° perpendicular to the cell’s cytoskeleton axis, importantly, earlier than the particular 4n-division system produced genome scale back diploid cells, we name “first cells”, due to health acquire. These 2n cells additionally confirmed the nuclear dependent 90° flip, which in each circumstances was related to cells gaining cell form modifications, herein illustrated from regular fibroblastic cells altering to roundness cells, indistinguishable from todays’ diagnostic most cancers cell morphology. This 3-D ball-like cell form, in metastasis, sque-ezing out and in between (?) endothelial cells within the lining of blood veins throughout disbursement, can be advantageous.
Familial Alzheimer’s Illness Mutations in PSEN1 Result in Untimely Human Stem Cell Neurogenesis
Mutations in presenilin 1 (PSEN1) or presenilin 2 (PSEN2), the catalytic subunit of γ-secretase, trigger familial Alzheimer’s illness (fAD). We hypothesized that mutations in PSEN1 scale back Notch signaling and alter neurogenesis. Expression knowledge from developmental and grownup neurogenesis present relative enrichment of Notch and γ-secretase expression in stem cells, whereas expression of APP and β-secretase is enriched in neurons.
We observe untimely neurogenesis in fAD iPSCs harboring PSEN1 mutations utilizing two orthogonal methods: cortical differentiation in 2D and cerebral organoid technology in 3D. That is partly pushed by diminished Notch signaling. We prolong these research to grownup hippocampal neurogenesis in mutation-confirmed postmortem tissue. fAD circumstances present mutation-specific results and a pattern towards diminished abundance of new child neurons, supporting a untimely getting old phenotype. Altogether, these outcomes help altered neurogenesis on account of fAD mutations and counsel that neural stem cell biology is affected in getting old and illness.
Knockdown of TRIM5α or TRIM11 will increase lentiviral vector transduction effectivity of human muller cells
The purpose of this research was to find out the expression and distribution of the host restriction elements (RFs) TRIM5α and TRIM11 in non-human primate (NHP) neural retina tissue and the human Muller cell line MIO-M1. As well as, experiments had been carried out to find out the impact of TRIM5α and TRIM11 knockdown on FIVGFP transduction of MIO-M1 cells with the purpose of devising methods to extend the effectivity of lentiviral (LV) gene supply vectors.
Immunofluorescence (IF) research indicated that TRIM5α and TRIM11 had been localized predominantly in nuclei inside the outer nuclear layer (ONL) and interior nuclear layer (INL) of NHP retina tissue. Double label IF indicated that TRIM5α and TRIM11 had been localized to among the retinal Muller cell nuclei. MIO-M1 cells expressed TRIM5α predominantly within the nucleus and TRIM11 primarily within the cytosol. FIVGFP transduction effectivity was considerably elevated, at Four and seven days put up transduction, in TRIM5α and TRIM11 knockdown clones (KD) in comparison with WT MIO-M1 cells.
As well as, pretreatment with the proteasome inhibitor MG132 elevated the transduction effectivity of FIVGFP in WT MIO-M1 cells. The nuclear translocation of NF-κB (p65), at 72 h put up FIVGFP transduction, was enhanced in TRIM5α and TRIM11 KD clones. The expression of TRIM5α and TRIM11 in macaque neural retina tissue and MIO-M1 cells point out the presence of those RFs in NHP retina and human Muller cells.
 (APC)) CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (APC) |
|
MBS6282774-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (Biotin)) CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (Biotin) |
|
MBS6282775-02mL |
MyBiosource |
0.2mL |
EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (Biotin) |
|
MBS6282775-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (FITC)) CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (FITC) |
|
MBS6282776-02mL |
MyBiosource |
0.2mL |
EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (FITC) |
|
MBS6282776-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (HRP)) CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (HRP) |
|
MBS6282777-02mL |
MyBiosource |
0.2mL |
EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (HRP) |
|
MBS6282777-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (PE)) CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (PE) |
|
MBS6282783-02mL |
MyBiosource |
0.2mL |
EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (PE) |
|
MBS6282783-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (AP)) CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (AP) |
|
MBS6282784-02mL |
MyBiosource |
0.2mL |
EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (AP) |
|
MBS6282784-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (APC)) CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (APC) |
|
MBS6282785-02mL |
MyBiosource |
0.2mL |
EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (APC) |
|
MBS6282785-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (Biotin)) CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (Biotin) |
|
MBS6282786-02mL |
MyBiosource |
0.2mL |
EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (Biotin) |
|
MBS6282786-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (FITC)) CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (FITC) |
|
MBS6282787-02mL |
MyBiosource |
0.2mL |
EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (FITC) |
|
MBS6282787-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (HRP)) CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (HRP) |
|
MBS6282788-02mL |
MyBiosource |
0.2mL |
EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (HRP) |
|
MBS6282788-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (PE)) CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (PE) |
|
MBS6282794-02mL |
MyBiosource |
0.2mL |
EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (PE) |
|
MBS6282794-5x02mL |
MyBiosource |
5x0.2mL |
EUR 4250 |
 (MaxLight 405)) CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 405) |
|
MBS6282778-01mL |
MyBiosource |
0.1mL |
EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 405) |
|
MBS6282778-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
 (MaxLight 490)) CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 490) |
|
MBS6282779-01mL |
MyBiosource |
0.1mL |
EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 490) |
|
MBS6282779-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
 (MaxLight 550)) CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 550) |
|
MBS6282780-01mL |
MyBiosource |
0.1mL |
EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 550) |
|
MBS6282780-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
 (MaxLight 650)) CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 650) |
|
MBS6282781-01mL |
MyBiosource |
0.1mL |
EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 650) |
|
MBS6282781-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
 (MaxLight 750)) CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 750) |
|
MBS6282782-01mL |
MyBiosource |
0.1mL |
EUR 980 |
CD14, CT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 750) |
|
MBS6282782-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
 (MaxLight 405)) CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 405) |
|
MBS6282789-01mL |
MyBiosource |
0.1mL |
EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 405) |
|
MBS6282789-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
 (MaxLight 490)) CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 490) |
|
MBS6282790-01mL |
MyBiosource |
0.1mL |
EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 490) |
|
MBS6282790-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
 (MaxLight 550)) CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 550) |
|
MBS6282791-01mL |
MyBiosource |
0.1mL |
EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 550) |
|
MBS6282791-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
 (MaxLight 650)) CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 650) |
|
MBS6282792-01mL |
MyBiosource |
0.1mL |
EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 650) |
|
MBS6282792-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
 (MaxLight 750)) CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 750) |
|
MBS6282793-01mL |
MyBiosource |
0.1mL |
EUR 980 |
CD14, NT (CD14, Monocyte differentiation antigen CD14, Myeloid cell-specific leucine-rich glycoprotein, CD14, Monocyte differentiation antigen CD14, urinary form, Monocyte differentiation antigen CD14, membrane-bound form) (MaxLight 750) |
|
MBS6282793-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4250 |
) MOUSE ANTI RAT CD45RA (B CELLS ONLY) |
|
MBS212979-1mg |
MyBiosource |
1mg |
EUR 805 |
MOUSE ANTI RAT CD45RA (B CELLS ONLY) |
|
MBS212979-5x1mg |
MyBiosource |
5x1mg |
EUR 3440 |
MOUSE ANTI RAT CD45RA (B CELLS ONLY) |
|
MBS212980-01mg |
MyBiosource |
0.1mg |
EUR 365 |
MOUSE ANTI RAT CD45RA (B CELLS ONLY) |
|
MBS212980-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1465 |
MOUSE ANTI RAT CD45RA (B CELLS ONLY) |
|
MBS212981-025mg |
MyBiosource |
0.25mg |
EUR 515 |
MOUSE ANTI RAT CD45RA (B CELLS ONLY) |
|
MBS212981-5x025mg |
MyBiosource |
5x0.25mg |
EUR 2145 |
 MagIso Pan Monocyte Cell Isolation Kit, Human |
|
WHK-B021 |
Creative Diagnostics |
20 tests, 200 tests |
Ask for price |
 CD45RA monoclonal antibody |
|
MB65786 |
Bioworld Biotech |
50ul |
EUR 275 |
|
|
|
Description: Mouse IgG2b. Liquid in PBS, pH 7.3, and 0.02% sodium azide. |
) CD14 (Monocyte Differentiation Antigen CD14, Myeloid Cell-specific Leucine-rich Glycoprotein) |
|
MBS6507133-01mg |
MyBiosource |
0.1mg |
EUR 800 |
CD14 (Monocyte Differentiation Antigen CD14, Myeloid Cell-specific Leucine-rich Glycoprotein) |
|
MBS6507133-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3445 |
) CD163 (Monocyte & Macrophage Marker) |
|
MBS4381414-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
CD163 (Monocyte & Macrophage Marker) |
|
MBS4381414-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
CD163 (Monocyte & Macrophage Marker) |
|
MBS4381414-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
CD163 (Monocyte & Macrophage Marker) |
|
MBS4381414-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
CD163 (Monocyte & Macrophage Marker) |
|
MBS4381414-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
) CD163 (Monocyte Macrophage Marker) |
|
MBS4381578-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
CD163 (Monocyte Macrophage Marker) |
|
MBS4381578-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
CD163 (Monocyte Macrophage Marker) |
|
MBS4381578-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
CD163 (Monocyte Macrophage Marker) |
|
MBS4381578-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
CD163 (Monocyte Macrophage Marker) |
|
MBS4381578-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
CD163 (Monocyte & Macrophage Marker) |
|
MBS4380519-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
CD163 (Monocyte & Macrophage Marker) |
|
MBS4380519-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
CD163 (Monocyte & Macrophage Marker) |
|
MBS4380519-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
CD163 (Monocyte & Macrophage Marker) |
|
MBS4380519-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
CD163 (Monocyte & Macrophage Marker) |
|
MBS4380519-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
CD163 (Monocyte & Macrophage Marker) |
|
MBS4380738-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
CD163 (Monocyte & Macrophage Marker) |
|
MBS4380738-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
CD163 (Monocyte & Macrophage Marker) |
|
MBS4380738-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
CD163 (Monocyte & Macrophage Marker) |
|
MBS4380738-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
CD163 (Monocyte & Macrophage Marker) |
|
MBS4380738-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
) Rat CD45Ra Antibody (B Cells Only) |
|
GWB-F09251 |
GenWay Biotech |
1 mg |
Ask for price |
Rat CD45Ra Antibody (B Cells Only) |
|
GWB-D60850 |
GenWay Biotech |
0.1 mg |
Ask for price |
Rat CD45Ra Antibody (B Cells Only) |
|
GWB-6A11BA |
GenWay Biotech |
0.25 mg |
Ask for price |
) CD14 (Monocyte/Macrophage Marker) |
|
MBS4381404-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4381404-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4381404-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4381404-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4381404-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380318-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380318-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380318-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380318-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380318-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380319-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380319-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380319-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380319-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380319-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380320-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380320-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380320-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380320-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380320-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380321-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380321-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380321-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380321-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
CD14 (Monocyte/Macrophage Marker) |
|
MBS4380321-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
 CD14, MONOCYTE, MACROPHAGE MARKER |
|
MBS608909-01mg |
MyBiosource |
0.1mg |
EUR 725 |
CD14, MONOCYTE, MACROPHAGE MARKER |
|
MBS608909-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3110 |
 (AP)) CD14 (Monocyte Differentiation Antigen CD14, Myeloid Cell-specific Leucine-rich Glycoprotein) (AP) |
|
MBS6372784-01mL |
MyBiosource |
0.1mL |
EUR 920 |
CD14 (Monocyte Differentiation Antigen CD14, Myeloid Cell-specific Leucine-rich Glycoprotein) (AP) |
|
MBS6372784-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3990 |
 APC) CD14 (Monocyte Differentiation Antigen CD14, Myeloid Cell-specific Leucine-rich Glycoprotein) APC |
|
MBS6372785-01mL |
MyBiosource |
0.1mL |
EUR 920 |
CD14 (Monocyte Differentiation Antigen CD14, Myeloid Cell-specific Leucine-rich Glycoprotein) APC |
|
MBS6372785-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3990 |
 (HRP)) CD14 (Monocyte Differentiation Antigen CD14, Myeloid Cell-specific Leucine-rich Glycoprotein) (HRP) |
|
MBS6372788-01mL |
MyBiosource |
0.1mL |
EUR 920 |
CD14 (Monocyte Differentiation Antigen CD14, Myeloid Cell-specific Leucine-rich Glycoprotein) (HRP) |
|
MBS6372788-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3990 |
 (PE)) CD14 (Monocyte Differentiation Antigen CD14, Myeloid Cell-specific Leucine-rich Glycoprotein) (PE) |
|
MBS6372794-01mL |
MyBiosource |
0.1mL |
EUR 920 |
CD14 (Monocyte Differentiation Antigen CD14, Myeloid Cell-specific Leucine-rich Glycoprotein) (PE) |
|
MBS6372794-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3990 |
 (Biotin)) CD14 (Monocyte Differentiation Antigen CD14, Myeloid Cell-specific Leucine-rich Glycoprotein) (Biotin) |
|
MBS6372786-01mL |
MyBiosource |
0.1mL |
EUR 920 |
CD14 (Monocyte Differentiation Antigen CD14, Myeloid Cell-specific Leucine-rich Glycoprotein) (Biotin) |
|
MBS6372786-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3990 |
 (FITC)) CD14 (Monocyte Differentiation Antigen CD14, Myeloid Cell-specific Leucine-rich Glycoprotein) (FITC) |
|
MBS6372787-01mL |
MyBiosource |
0.1mL |
EUR 920 |
CD14 (Monocyte Differentiation Antigen CD14, Myeloid Cell-specific Leucine-rich Glycoprotein) (FITC) |
|
MBS6372787-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3990 |
 Monocyte differentiation antigen CD14 |
|
AP81477 |
SAB |
1mg |
EUR 2640 |
|
|
Monocyte differentiation antigen CD14 |
|
AP81528 |
SAB |
1mg |
EUR 2640 |
|
|
Monocyte differentiation antigen CD14 |
|
AP81659 |
SAB |
1mg |
EUR 2640 |
|
|
Monocyte differentiation antigen CD14 |
|
AP81660 |
SAB |
1mg |
EUR 2640 |
|
|
 Human CD45RA Monoclonal antibody |
|
45RAF-100T |
ImmunoStep |
100 test |
EUR 501.6 |
Human CD45RA Monoclonal antibody |
|
45RAPC7-100T |
ImmunoStep |
100 test |
EUR 358.6 |
Human CD45RA Monoclonal antibody |
|
45RAA-100T |
ImmunoStep |
100 test |
EUR 281.6 |
 CD45RA Monoclonal antibody [Clone: ] |
|
158-4D3-100ug |
Biologicals |
100 ug |
EUR 141.79 |
|
|
|
Description: MAbs against CD45 can be used to differentiate lymphomas from carcinomas. In Hodgkin’s disease CD45 is usually not expressed. |
CD45RA Monoclonal antibody [Clone: ] |
|
158-4D3-1mg |
Biologicals |
1 mg |
EUR 897.6 |
|
|
|
Description: MAbs against CD45 can be used to differentiate lymphomas from carcinomas. In Hodgkin’s disease CD45 is usually not expressed. |
CD45RA Monoclonal antibody [Clone: ] |
|
158-4D3-500ug |
Biologicals |
500 ug |
EUR 479.6 |
|
|
|
Description: MAbs against CD45 can be used to differentiate lymphomas from carcinomas. In Hodgkin’s disease CD45 is usually not expressed. |
CD45RA Monoclonal antibody [Clone: ] |
|
111-1C5-100ug |
Biologicals |
100 ug |
EUR 141.79 |
|
|
|
Description: MAbs against CD45 can be used to differentiate lymphomas from carcinomas. In Hodgkin’s disease CD45 is usually not expressed. |
CD45RA Monoclonal antibody [Clone: ] |
|
111-1C5-1mg |
Biologicals |
1 mg |
EUR 897.6 |
|
|
|
Description: MAbs against CD45 can be used to differentiate lymphomas from carcinomas. In Hodgkin’s disease CD45 is usually not expressed. |
Our knowledge point out that even partial knockdown of TRIM5α or TRIM11, or a brief proteasome inhibitor pretreatment, can enhance the transduction effectivity of a LV vector.
